Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults.
Niloufar KavianAsmaa HachimAthena Py LiCarolyn A CohenAlex Wh ChinLeo Lm PoonVicky J FangNancy Hiu Lan LeungBenjamin J CowlingSophie A ValkenburgPublished in: Clinical & translational immunology (2020)
The early, broadly reactive and long-lived antibody response of FluAd indicates a potential advantage of this vaccine, particularly in years when there is a mismatch between the vaccine strain and the circulating strain of influenza viruses.